Cargando…
Polygenic risk scores: An overview from bench to bedside for personalised medicine
Since the first polygenic risk score (PRS) in 2007, research in this area has progressed significantly. The increasing number of SNPs that have been identified by large scale GWAS analyses has fuelled the development of a myriad of PRSs for a wide variety of diseases and, more recently, to PRSs that...
Autores principales: | Cross, Benjamin, Turner, Richard, Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692112/ https://www.ncbi.nlm.nih.gov/pubmed/36437929 http://dx.doi.org/10.3389/fgene.2022.1000667 |
Ejemplares similares
-
Editorial: Translational medicine in the diagnosis and treatment of cancer based on oncogenetics: from bench to bedside
por: Cao, Rui, et al.
Publicado: (2023) -
Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022) -
Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2015) -
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011) -
Bench to Bedside: Proteomic Biomarker Analysis of Cerebrospinal Fluid in Patients With Spondylomyelopathy
por: Fiani, Brian, et al.
Publicado: (2021)